COMBINATION THERAPIES TARGETING TUMOR-ASSOCIATED STROMA OR TUMOR CELLS AND TOPOISOMERASE Read more about COMBINATION THERAPIES TARGETING TUMOR-ASSOCIATED STROMA OR TUMOR CELLS AND TOPOISOMERASE US Patent 10,758,614Filed on 2015-06-09
COMBINATION THERAPIES TARGETING TUMOR-ASSOCIATED STROMA OR TUMOR CELLS AND MICROTUBULES Read more about COMBINATION THERAPIES TARGETING TUMOR-ASSOCIATED STROMA OR TUMOR CELLS AND MICROTUBULES US Patent 11,033,620Filed on 2015-06-09
COMBINATION THERAPIES USING PLATINUM AGENTS AND AGENTS THAT TARGET TUMOR-ASSOCIATED STROMA OR TUMOR CELLS Read more about COMBINATION THERAPIES USING PLATINUM AGENTS AND AGENTS THAT TARGET TUMOR-ASSOCIATED STROMA OR TUMOR CELLS US Patent 10,434,174Filed on 2015-06-09
COMBINATION THERAPIES USING AGENTS THAT TARGET TUMOR ASSOCIATED STROMA OR TUMOR CELLS Read more about COMBINATION THERAPIES USING AGENTS THAT TARGET TUMOR ASSOCIATED STROMA OR TUMOR CELLS US Patent 10,758,613Filed on 2015-06-09
COMBINATION THERAPIES USING AGENTS THAT TARGET TUMOR-ASSOCIATED STROMA OR TUMOR CELLS AND ALKYLATING AGENTS Read more about COMBINATION THERAPIES USING AGENTS THAT TARGET TUMOR-ASSOCIATED STROMA OR TUMOR CELLS AND ALKYLATING AGENTS US Patent 10,799,584Filed on 2015-06-09
COMBINATION THERAPIES USING AGENTS THAT TARGET TUMOR ASSOCIATED STROMA OR TUMOR CELLS AND OTHER PATHWAYS Read more about COMBINATION THERAPIES USING AGENTS THAT TARGET TUMOR ASSOCIATED STROMA OR TUMOR CELLS AND OTHER PATHWAYS US Patent 10,758,526Filed on 2015-06-09
Combination Therapies Using Agents That Target Tumor-Associated Stroma or Tumor Cells and Tumor Vasculature Read more about Combination Therapies Using Agents That Target Tumor-Associated Stroma or Tumor Cells and Tumor Vasculature US Patent 11,034,757Filed on 2015-06-09
Glypican 2 As A Cancer Marker And Therapeutic Target Read more about Glypican 2 As A Cancer Marker And Therapeutic Target Patent Cooperation TreatyPCT/US2016/060974Filed on 2016-11-08
METHODS FOR DETECTING EXPRESSION OF LNC-FANCI-2 IN CERVICAL CELLS Read more about METHODS FOR DETECTING EXPRESSION OF LNC-FANCI-2 IN CERVICAL CELLS US Patent 10,487,365Filed on 2016-09-20
Optimal Dosing Of Heterodimeric Interleukin-15 (IL-15) Read more about Optimal Dosing Of Heterodimeric Interleukin-15 (IL-15) US Patent 10,335,460Filed on 2017-01-24